Among the relatively few naturally occurring nucleosides, which contain ribose bound to a carbon atom of the heterocyclic aglycone. some-the formycins. oxazinomycin, pyrazomycin, and showdomycin-appear to act as antagonists to essential metabolites, whereas others-pseudo-uridine, also formycin Aappear to resemble their respective counterparts-uridine, adenosine-to such degree as tobe capable of functioning as metabolic substitutes. Recent sturlies have focused on the effects of C-nucleosides on ribonucleotide reductase and purine ribonucleoside phosphorylase, on the mode of action of C-nucleosides and on their biosynthesis. The properties of polymers and co-polymers of formycin have been interpreted in terms of the relative contributions of the 'syn-' and 'anti-' conformations of this C-nucleoside (Ward, Reich).
have focused on the effects of C-nucleosides on ribonucleotide reductase and purine ribonucleoside phosphorylase, on the mode of action of C-nucleosides and on their biosynthesis. The properties of polymers and co-polymers of formycin have been interpreted in terms of the relative contributions of the 'syn-' and 'anti-' conformations of this C-nucleoside (Ward, Reich) .
The observation of specific reversal of anti-viral activity of pyrazomycin by uridine alone points to pyrimidine biosynthetic pathways as the possible vulnerable site for growth inhibition. Support for this notion derives from experiments with orotidylic decarboxylase of rat liver, 50 per cent inhibition of activity being observed at Ievels of 5 x 10-8 M pyrazomycin-5'-phosphate. The antimicrobial activity of oxazinomycin (Haneishi et aL Sankyo Ltd., Tokyo) was efficiently reversed only by deoxycytidine. perhaps suggesting nucleotide reductase as site of action. The synthesis of showdomycin and of oxoformycin has recently been accomplished (F. Sorm et al., Prague), while 'pseudo-azauridine' has been obtained by conversion ofpseudo-uridine (Sorm).
The agricultural potential of formycin B against rice plant disease has been noted but no medical usefulness has thus far been demonstrated for members of the C-nucleoside class. The preparation of additional C-nucleosides by synthesis or by modification of naturally available materials, together with a detailed understanding of structure-activity relationships, hopefully will assist in the realization of the therapeutic potential of this versatile class of agents.
The first carbon-linked nucleoside, pseudo-uridine (I) 1 • 2 , discovered in 1959, resembles uridine (II), in its shape andin the disposition of its functional hydrogen bonding sites, to such a degree that it can efficiently substitute for this metabolite in enzymic conversion at the nucleotide 3 as weil as at the polynucleotide level 4 • lts failure to support the growth of the uracil-E.cali mutant W 3362 5 is presumably due to stability of its ribose-to-carbon linkage and represents a rare instance in which pseudo-uridine is not capable of replacing uridine.
When reflecting on the comparison and resemblance of molecules, the near-identity of the pair uridine-pseudouridine in biochemical conversions can be envisaged, but not necessarily predicted, from an inspection of their structural formulae.
On the other band, 3-iso-adenosine (111) 6 and 7-deaza-adenosine (tubercidin) (IV) 7 , nucleosides with structures closely resembling that of adenosine, are cytotoxic toward mammalian cells 6 and thus in this system appear to act as antagonists rather than as substitutes.
. Among C-nucleoside antibiotics 8 -14 , formycin A 8 (V) and B 9 (VI), show-domycin 10 (VII), pyrazomycin 11 (VIII) and oxazinomycin 12 (IX), modification products 13 (X) and synthetic analogues 14 , the type of biological activity encountered varies from near-perfect substitution (formycin A for adeno-. sine 15 ) to powerful antagonism (inhibition ofmurine tumours by formycin 8 ).
The pattern of inhibition shown by showdomycin (VII) is complex; this antibiotic acts both as a uridine antagonist 17 and as a powerful SH-reactorl7,Is.
Detection of molecular resemblance between metabolite and inhibitor at the enzyme site has been approached in our laboratories by a study of reversal of anti-viral activity in vitro. Replicating virus growing in tissue culture presents an efficient, informative ('in vivo') system which avoids the complexities-e.g. absorption and metabolism-of animal studies and is more meaningful than in vitro enzyme studies al one.
· In this manner we have studied viral inhibition-reversal patterns of the fermentation product .mycophenolic acid 19 (XI), an antibiotic of low toxicity recently shown to inhibit growth of several murine tumours 20 , of the C-nucleoside pyrazomycin (VIII), and of a small number of known antimetabolites with established mode 'of action.
Recent surveys 21 dealing with C-nucleoside research include a penetrating discussion of the relationship between nucleoside conformation and biological activity by Ward and Reich 21 a. Suhadolnik has thoroughly reviewed the pertinent Iiterature up to 1970 21 b. Mention will be made, below, ofreports that have appeared since that date.
VIRAL INHIBITION AND REVERSAL BY METABOLITES
Briefly, the agar-diffusion method 22 used in this work consists of a monolayer of BS-C-1 cells infected with virus and an overlay of agar on which small filter paper discs impregnated with the inhibitor substances are applied. F ollowing incubation at 37° for 72 hours, the virus is inactivated, the surviving cells fixed to the glass and stained. The cytopathological and cytotoxic effects are estimated by visual and microscopic inspection. Plaque reduction, virus multiplication and cellular competence can also be estimated.
For reversal studies the inhibitory substance is incorporated in the agar overlay at concentrations affording essentially complete protection. Salutions of metabolites applied to paper discs reveal reversal of anti-viral action as zones of virus break-through. Reduction of vaccinia virus plaque count was noted with a fermentation broth subsequently shown to contain mycophenolic acid 22 . The cytoprotective effect of 10 J,tg/ml of mycophenolic acid was effectively reversed by guanosine, guanylic acid, and deoxyguanylic acid (Ref. 22 , Table 1 , Figures  2 and 3) . Guanine, due perhaps to its low solubility, was less effective, while xanthosine, inosine, and other purine or pyrimidine nucleosides were ineffective as reversal agents.
This surprising observation of reversal by guanine species raises the intriguing notion of a close molecular resemblance of the carboxylic acid (XI), probably as the anion, to a guanine related nucleotide, e.g. xanthylic acid (XII). Such resemblance, although not readily predicted on the basis of structural formulae (XI and XII)~ is conceivable, nevertheless, in terms of similarity of fit of the three-dimensional molecules to a receptor site.
Guided by the observation of reversal by guanosine~ guanylic synthetase, isolated from susceptible murine tumours, was in fact inhibited by mycophenolic acid 23 . Investigators elsewhere independently showed that inosinic dehydrogenase, also, is inhibited by XI 24 . Though these findings strongly support the existence of a direct metaboliteantagonist relationship for the pair XI-XII, the reality of such a relationship and of the underlying molecular resemblance remains to be proved. If correct, perhaps XI itself could be viewed as a C-nucleoside type of antimetabolite? A molecular resemblance between the anti-fungal agent griseofulvin and adenosine has been mentioned previously as a basis for inhibition and reversal phenomena observed 25 • To the cancer chemotherapist the notion of a purine antagonist (XI) which itself it not a purine derivative is an attractive one. A carboxylic acid rather than a phosphate, conversion of mycophenolic acid (XI) to a triphosphate stage and incorporation into nucleic acid, a mode of action often noted with nucleoside antagonists 26~ is constitutionally precluded. F or these and other reasons the search for and the design of molecules which, in spite of a Iack of evident similarity, behave as antagonist (as does XI) to a critical metabolite, present achallenge of considerable importance.
PYRAZOMYCIN-5'-PHOSPHATE-OROTIDYLIC ACID PAIR
In the course of screening fermentation broths for anti-viral activity, significant growth inhibition was noted by a culture of Streptomyces candidus. Inhibition of vaccinia virus 16 by the active component, pyrazomycin 11 , a crystalline, water-soluble compound of composition C 9 H 13 N 3 0 6 was found to be reversed specifically by uridine (li) and by uridylic acid but not by cytidine. A structure related to uridine was a logical proposal. Among the limited number of possible structures that of the C-nucleoside, 3(5)-ß-oribofuranosyl-4-hydroxy-pyrazole-5(3)-carboxamide (VIII), was favoured. This structure was confirmed by physical studies (H' 1 occurs at 5 p.p.m. in the n.m.r. spectrum) and by chemical degradation 11 . U sing the method described above, reversal studies with a small number of known anti-metabolites (see Table 1 ) demonstrate that the respective These findings ( Table 1 ) testify to the accuracy and dependability of in vitro reversal sturlies as an aid in structure determination as weil as in pinpointing probable sites of enzymatic vulnerability.
In this manner, uridine reversal ofpyrazomycin activity points to orotidylic decarboxylase inhibition as a probable mode of action. Pyrazomycin-5'-phosphate (XIII), prepared from pyrazomycin and p-nitro-phenylphosphate with the aid of carrot nucleoside phosphotransferase 31 . was shown to be a powerful inhibitor of this decarboxylase, 50 per cent reduction of 14 C0 2 release being effected by a concentration of 5 x 10-8 M 16 . 6-Azauridylic acid produces a similar inhibition only at twenty-fold higher Ievels, while pyrazomycin (VIII) itself is essentially without activity.
Presumably, pyrazomycin-5' -phosphate (XIII) and orotidylic acid (XIV) share chemical, physical and spatial characteristics to such an extent that resemblance of molecular architecture is realized for the decarboxylase, a resemblance perhaps envisaged more readily by the medicinal ehernist a posteriori than recognized a priori.
REPORTED OBSERVATIONS ON MODE OF ACTION
Published articles 17 a, 32 report that the inhibition of mammalian cell growth by showdomycin (VII) can be reversed by various nucleosides as weil as by thiol-containing compounds. A clear resemblance to a particular metabolite remains difficult to define.
An analogue of adenosine, formycin A (V) in the form of its mono-, di-, or tri-phosphate can, on the one hand, efficiently replace adenine-nucleotides in several enzymatic conversions, including polynucleotide phosphorylase (of E. coli) 33 and tRNA-CCA pyrophosphorylase 33 . The latter reaction produces functional tRNA in which formycin replaces the terminal adenosine unit.
On the other hand formycin-5'-phosphate isapotent inhibitor ofadenylate synthesis by adenine phosphoribosyltransferase 34 of Ehrlich ascites cells. In mammalian cells formycin supresses synthesis ofDNA, RNA, and protein 35 . F ormycin also inhibits certain murine tumours including the leukaemia L1210, influenza A 1 virus and X anthomonas oryzae, the pathogenic bacterium causing disease of rice plants 8 • 36 . This dualistic behaviour and other characteristics of formycin, especially as a unit of homo-and hetero-polynucleotides, have been related to its unusual conformational features 213 '
37 . Due to increased band length of the C-C glycosidic linkage in formycin, compared to the C-N band in purine nucleosides, the rotational barrier about this Iinkage is lowered. Consequently, the syn-conformation (V) for formycin is favoured to a degree which depends on the nature of the polynucleotide: syn (V) in neutral polyformycin and a mixture of syn (V) and anti (XV) in single-stranded co-polymers 213 • 37 .
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Returning to the theme of this paper, namely the recognition of actual molecular resemblance in biochemical interaction, attention is directed toward a comparison (Ref. 38, Figure 3 ) in which a formycin-3'-phosphate unit ( of poly-F) in the syn-conformation is superimposed on a 3' -cytidylic unit (of poly-C) in the anti-conformation. The near-perfect overlap of functional hydrogen-bonding sites (N 7 and N 1 of F with N 4 and N 3 of C) signifies a close resemblance between the 'purine '-and the pyrimidine nucleotide. This resemblance serves to explain 38 the surprising susceptibility of polyformycin to the transphosphorylation step (yielding 2',3'-cyclic-FMP) of bovine pancreatic ribonuclease A, an enzyme weil known for its rigorous specificity for pyrimidine nucleotides (hydrolysed to the 3' -phosphate).
In this instance, the adenosine-analogue formycin A due to its C-nucleoside structure, reacts as, and resembles, a pyrimidine nucleoside. Now, while slowly learning certain principles of molecular resemblance from these occasional examples acquired through biochemical or biological observations, the chemotherapist strongly feels the need oflearning to predict and design such resemblance of molecules and to express their molecular architecture in terms allowing facile, effective comparison. [An example of unsuspected resemblance mentioned in recent pu blications is that of the pair erythromycin and lincomycin 39 • 40 ]. An inosine analogue. the C-nucleoside formycin B 9 (VI) is produced from formycin A by the action of adenosine deaminase 41 . Presumably acting at the nucleoside Ievel, formycin B inhibits X. oryzae by preventing exogenously supplied nucleosides from entering the cel1
.
The inhibition of S. aureus 209B (minimum inhibitory concentration 1.6 ).lg/ml) by oxazinomycin (IX), is effectively reversed by deoxycytidine and by other pyrimidine-but not by purine-nucleosides 12 . Oxazinomycin also inhibits Ehrlich ascites in mice 12 . Enzymatic information and mechanistic studies have not been reported.
In summary, C-nucleosides represent an important dass of antibiotics due to their close analogy to the normal nucleoside metaboli tes. The varied effects of C-nucleosides on numerous enzymatic conversions render their further investigation as potential chemotherapeutic agents a worthwhile undertaking.
SYNTHESIS AND BIOSYNTHESIS
In a further extension of their nucleoside investigations Sorm. Farkas and their associates in Prague have achieved a first total synthesis of showdomycin (VII), ozonolysis of suitably protected 1-(ß-n-ribofuranosyl)-2,4,6-trimethoxybenzene representing a critical step in producing the methyl ribosyl-glyoxalate required for the construction of the heterocyclic ring 1 4c.
The synthesis of 'pseudo-6-azauridine', involving ozonolysis of natural pseudo-uridine, has been reported earlier by Sonn and co-workers 1 4<1. In another approach, ribosyl-diazomethane, obtained from 1-cyano-ribose, was allowed to react with diethyl acetylenedicarboxylate yielding a substituted 3-ribosylpyrazole which was converted in four steps to oxoformycin 14 b, identical to the product obtained by metabolic oxidation of formycin A (V) or B (VI) in vivo 43 . Several substituted 7-substituted 3-(ß-n-ribofuranosylpyrazolo)- [ 4,3-d] pyrimidines (X) have been prepared from the 7-chloro-analogue (Xe), itself obtained from formycin B (VI) 44 . The 7-hydrazino-(Xd) and the 7-hydroxylamino-(Xe) members of this group differ in their physical properties (u.v. spectra) from these same compounds prepared earlier 45 • 40 from the 7-thiol compound (Xa). The interpretation of the biological data of these agents therefore must wait clarification.
Conversion of formycin B to 4-amino-3-(ß-n-ribofuranosyl)-pyrazole-5-carboxamide (XVI) by Townsend and his co-workers 47 makes this aminoanalogue of pyrazomycin available for biological testing. The evident significance of this agent stems from its analogy to the purine precursor, aminoimidazole-carboxamide-ribonucleotide (AICAR).
In order to study biosynthetic pathways leading to C-nucleosides, Suhadolnik has begun the investigation of showdomycin (VII) formation by cultures of S. showdoensis using ribose-l-14 C and acetate-1-and -2-14 C 48 • 49 • Ribose is utilized in toto. Acetate serves to form two or perhaps all four carbon atoms of the maleimide-moiety without evidence for the participation of C 4 -dicarboxylic acid intermediate of the tricarboxylic acid cycle. Fluoroacetate does not inhibit incorporation of acetate into the maleimidering system 48 • 49 .
